Curis, Inc. (CRIS)
0.5911
-0.09
(-13.64%)
USD |
NASDAQ |
Apr 16, 16:00
0.619
+0.03
(+4.72%)
After-Hours: 20:00
Curis Free Cash Flow : -27.20M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -77.20M |
| Plus Therapeutics, Inc. | -20.84M |
| Windtree Therapeutics, Inc. | -15.12M |
| Halozyme Therapeutics, Inc. | 644.59M |
| AIM ImmunoTech, Inc. | -11.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.371M |
| Cash from Investing (Quarterly) | 2.50M |
| Cash from Financing (Quarterly) | -0.119M |
| Free Cash Flow Per Share (Quarterly) | -0.4046 |
| Free Cash Flow to Equity (Quarterly) | 22.61M |
| Free Cash Flow to Firm (Quarterly) | -6.057M |
| Free Cash Flow Yield | -350.3% |